drugset / Trial / NCT00710515

Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies

NCT00710515

Phase 1 Completed 30 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to test if the levels of AZD6244 in blood are affected by taking food at the same time as the capsules compared to taking capsules on an empty stomach

Timeline

Start
2008-07
Primary completion
2009-04
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Selumetinib Small molecule 75 mg

Indications